Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJiangsu Famous Medical Technology Co., Ltd.
About this trial
This is a nationwide cohort study on integrated traditional Chinese and Western medicine for colorectal cancer. The aim is to elucidate the distribution patterns of TCM syndromes in colorectal cancer and colorectal adenoma, reveal the relationship between TCM syndromes and diagnosis, prognosis, and prognosis. Based on biological samples, a phenotypic omics study of TCM syndromes in colorectal cancer and colorectal adenoma is conducted.
Eligibility criteria
Qualifiers
The patient is over 18 years old;
The patient meets the diagnostic criteria for colorectal cancer;
The patient has not received anti-tumor treatment such as surgery, chemotherapy, radiotherapy, targeted therapy, or immunity in the past;
The patient voluntarily participated in this study and signed an informed consent form.
Disqualifiers
Combined with other malignant tumors;
The patient has severe cognitive impairment, dementia, and various mental disorders.
The patient had a history of malignancy;
The patient has severe cognitive impairment, dementia, and various mental disorders.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50,000 Participants
are grouped into 3 trial groupsLocations
Sponsors and collaborators
Jiangsu Famous Medical Technology Co., Ltd.
Lead sponsor
Jiangsu Province Hospital of Traditional Chinese Medicine
Collaborator
Peking University Cancer Hospital & Institute
Collaborator
Fujian Cancer Hospital
Collaborator
Hubei Cancer Hospital
Collaborator
Shandong Cancer Hospital and Institute
Collaborator
Shanxi Province Cancer Hospital
Collaborator
Sichuan Cancer Hospital and Research Institute
Collaborator
Yunnan Cancer Hospital
Collaborator
Zhejiang Cancer Hospital
Collaborator
Xiangya Hospital of Central South University
Collaborator
Chongqing University Cancer Hospital
Collaborator
The First Affiliated Hospital of Anhui Medical University
Collaborator
First Affiliated Hospital of Guangxi Medical University
Collaborator
First Affiliated Hospital of Harbin Medical University
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine
Collaborator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborator
Tianjin Medical University Cancer Institute and Hospital
Collaborator
Gansu Cancer Hospital
Collaborator
Source ClinicalTrials.gov